Ayabudge LLC, 10% Owner at Humacyte, Inc. (HUMA), sold 1,069,460 shares at $2.63 ($3.0M) on 2022-12-15, disclosed to the SEC on 2022-12-15.
Open-market sale of $3.0M HUMA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 330,000 | $937K | 31.7% |
| 2 | $2.76 | 276,304 | $763K | 25.8% |
| 3 | $2.76 | 276,304 | $763K | 25.8% |
| 4 | $2.63 | 93,426 | $246K | 8.3% |
| 5 | $2.63 | 93,426 | $246K | 8.3% |
| Total | $2.76 avg | 1,069,460 |
| $3.0M |
| 100% |
| Filing → |
| HUMA | SELL | 2023-06-15 | $12.7M | — | Filing → |
| HUMA | SELL | 2023-05-26 | $7.2M | — | Filing → |
| HUMA | SELL | 2022-12-19 | $1.2M | — | Filing → |